TGN1412 drug molecule. Computer model showing the secondary structure of the drug TGN1412. This drug was shown to have serious side effects during a c

---

TGN1412 drug molecule. Computer model showing the secondary structure of the drug TGN1412. This drug was shown to have serious side effects during a clinical trial in the UK in 2006 when it caused systemic failure in 6 volunteers. The drug is a monoclonal antibody that activates T cells by binding to CD28 receptors on the cell's surface. T cells are a type of white blood cell and a component of the body's immune system.

---

Size: 4172px × 4170px
Photo credit: © DR TIM EVANS/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: agonist, antibody, artwork, beta, biochemical, biochemistry, cd28, cd28-supermab, chemical, chemistry, clinical, compound, compounds, computer, controversial, drug, effect, effects, failure, illustration, immunomodulatory, medical, medicine, model, molecular, molecule, molecules, monoclonal, pharmacological, pharmacology, protein, proteins, secondary, sheet, sheets, side, single, structure, tgn1412, trial